{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:06:46Z","timestamp":1789074406018,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179257","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:42:56Z","timestamp":1787388176000},"page":"179257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["10-Hydroxy-2-decenoic acid, a bioactive component of royal jelly, induces p53-Mediated apoptosis in cholangiocarcinoma in vitro and in vivo"],"prefix":"10.1016","volume":"1033","author":[{"given":"Guohong","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179257_bib1","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.3390\/molecules26227021","article-title":"Anti-tumor effects of queen bee acid (10-Hydroxy-2-Decenoic acid) alone and in combination with cyclophosphamide and its cellular mechanisms against ehrlich solid tumor in mice","volume":"26","author":"Albalawi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179257_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/B515619J","article-title":"Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents","volume":"24","author":"Altmann","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejphar.2026.179257_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113380","article-title":"TTDA inhibited apoptosis by regulating the p53-Bax\/Bcl2 axis in glioma","volume":"331","author":"Bai","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.179257_bib4","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/molecules25143291","article-title":"Royal Jelly-A traditional and natural remedy for postmenopausal symptoms and aging-related pathologies","volume":"25","author":"B\u0103lan","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179257_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.6004\/jnccn.2014.0112","article-title":"Hepatobiliary cancers, version 2.2014","volume":"12","author":"Benson","year":"2014","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ejphar.2026.179257_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.179257_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107099","article-title":"Natural products for combating multidrug resistance in cancer","volume":"202","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179257_bib8","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1039\/D1FO01070K","article-title":"Selenium-rich royal jelly inhibits hepatocellular carcinoma through PI3K\/AKT and VEGF pathways in H22 tumor-bearing mice","volume":"12","author":"Chi","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2026.179257_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179257_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156816","article-title":"The neuroprotective effect of 10-hydroxy-2-decenoic acid in traumatic brain injury by inhibiting copper-mediated neuronal pyroptosis","volume":"142","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179257_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2026.179257_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156534","article-title":"10-Hydroxydec-2-enoic acid reduces vascular smooth muscle cell inflammation via interacting with toll-like receptor 4","volume":"140","author":"Jia","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179257_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3350\/cmh.2021.0287","article-title":"Intrahepatic cholangiocarcinoma: tumour heterogeneity and its clinical relevance","volume":"28","author":"Komuta","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179257_bib15","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.3390\/ijms20194662","article-title":"Royal jelly and its components promote healthy aging and longevity: from animal models to humans","volume":"20","author":"Kunugi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179257_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular pathogenesis of cholangiocarcinoma","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2026.179257_bib17","doi-asserted-by":"crossref","first-page":"14415","DOI":"10.1021\/acs.jafc.1c05942","article-title":"Royal jelly proteins and their derived peptides: preparation, properties, and biological activities","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2026.179257_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3042636","article-title":"10-HDA induces ROS-mediated apoptosis in A549 human lung cancer cells by regulating the MAPK, STAT3, NF-\u03baB, and TGF-\u03b21 signaling pathways","author":"Lin","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejphar.2026.179257_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-024-44795-1","article-title":"Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179257_bib20","doi-asserted-by":"crossref","first-page":"20918","DOI":"10.1021\/acs.jafc.4c03367","article-title":"Inhibitory effects of royal jelly and its functional components on the proliferation of MKN-28 gastric cancer cells","volume":"72","author":"Ma","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2026.179257_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","article-title":"Cholangiocarcinoma: modern advances in understanding a deadly old disease","volume":"45","author":"Malhi","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179257_bib22","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.3390\/ijms25116023","article-title":"Royal jelly: biological action and health benefits","volume":"25","author":"Or\u0161oli\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179257_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma--controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179257_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179257_bib25","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/acs.jmedchem.0c02026","article-title":"Marine natural products: a potential source of anti-hepatocellular carcinoma drugs","volume":"64","author":"Ren","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179257_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2026.179257_bib27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179257_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-Paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2026.179257_bib29","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/D3AN01840G","article-title":"Exploring the in vitro potential of royal jelly against glioblastoma and neuroblastoma: impact on cell proliferation, apoptosis, cell cycle, and the biomolecular content","volume":"149","author":"Simsek Ozek","year":"2024","journal-title":"Analyst"},{"key":"10.1016\/j.ejphar.2026.179257_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179257_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156062","article-title":"Network pharmacology provides new insights into the mechanism of traditional Chinese medicine and natural products used to treat pulmonary hypertension","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179257_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154940","article-title":"Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites","volume":"118","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179257_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114748","article-title":"Bisindole natural products: a vital source for the development of new anticancer drugs","volume":"243","author":"Xu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179257_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.phymed.2016.07.003","article-title":"Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3","volume":"23","author":"Zhang","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179257_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.179257_bib36","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1468-3083.2012.04707.x","article-title":"10-Hydroxy-2-decenoic acid prevents ultraviolet A-induced damage and matrix metalloproteinases expression in human dermal fibroblasts","volume":"27","author":"Zheng","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:09:24Z","timestamp":1789070964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0014299926007399"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179257","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"10-Hydroxy-2-decenoic acid, a bioactive component of royal jelly, induces p53-Mediated apoptosis in cholangiocarcinoma in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179257"}}